DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences (AbAg) | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | Novagali | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma (ex-Nova Decision) | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |


Parse error: syntax error, unexpected '/', expecting T_VARIABLE or '$' in /homepages/1/d315158125/htdocs/Pharmaclient/biotech/fonctions.inc(162) : eval()'d code on line 1
$texte= " * NETRIS-PHARMA *

 

2008 - Rhône-Alpes
Lyon
www.no-website.net

 

Discovery, Drugs
Key words: Breast cancer, Metastasis, Dependence receptors, Targeted Therapy
Mission: to develop therapeutic compounds for the treatment of cancer, in particular of breast cancer and NSC Lung cancer
Clients: undisclosed
contact@netrispharma.com

Age: " . AGE() . " year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Personal venture |
Managing Dir.-CEO: Bernet (Agnès) [co-founder, born 1968, CNRS]
Sc.Dir.-CSO: Bernet (Agnès)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned (registered capital 2009 = 0.04 M€)

Turnover (M€) : n.a.
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Cancers
Position : Proof-of-Concept
Company confirm : 30-Sep-2008

 

History
DATEMILESTONETYPETIME
2009 .09 Nomination : Agnès Bernet, as CEO, replacing Rodolphe Pasquier-Desvignes ORGN [1 year]

Actualisation / Updating:

"
2008 .06 Company founded by Patrick Mehlen [Lyon University, CNRS, as head of scientific board], Agnès Bernet [Lyon University], and Rodolphe Pasquier-Desvignes, as CEO ORGF [0 year]

Actualisation / Updating: 3-May-2011

" ;

   

Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2011. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende